Nanette Barragán actually said...
It sounds like we are playing a middleman for prescription drugs to be on a preferred list.
Context
Barragan critiques the role of middlemen in prescription drug pricing.
04/09/2019
Barragan critiques the role of middlemen in prescription drug pricing.